Cinacalcet
Cinacalcet Hydrochloride, Sensipar
Calcium-sensing Receptor Agonist
NADAC/unit
$0.4064
No Shortage
10 Manufacturers
28 ANDAs
Cinacalcet is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. ( 1.1 ) Limita....
vs. brand Cinacalcet Hydrochloride: Generic saves up to 96% per unit
Market Intelligence
2025-12-17 Class II Recall: Cipla USA, Inc.
2025-12-17 Class II Recall: Cipla USA, Inc.
2025-12-17 Class II Recall: Cipla USA, Inc.
2025-08-06 Class II Recall: Strides Pharma, Inc.
2024-12-11 Class II Recall: Aurobindo Pharma USA Inc
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCIPLA LTDDR REDDYS LABORATORIES LTDPIRAMAL HEALTHCARE UK LTDSTRIDES PHARMA GLOBAL PTE LTDSUN PHARMACEUTICAL INDUSTRIES LTDWATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.